VC-backed Pandion Therapeutics debuts IPO

Watertown, Massachusetts-based Pandion Therapeutics Inc, a developer of treatments for patients suffering from autoimmune diseases, has raised $135 million for its IPO after pricing its 7.5 million shares at $18 per share.